Uplizna (Inebilizumab-cdon Injection)

  • Brand Name: Uplizna
  • Innovator Brand Name: Uplizna
  • API: Inebilizumab-cdon
  • Dosage Form: 1 Vial (Per Box)
  • Strength: 100 mg/10 mL
  • Manufacturer Name: Viela Bio, Inc.
Get Price
Category:

Description

Uplizna (Inebilizumab-cdon Injection) Uses

Uplizna (Inebilizumab-cdon) is a CD19-directed cytolytic antibody used for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive.

Dosage: Inebilizumab-cdon is administered as an intravenous infusion. The recommended dosage is: Initial dose: 300 mg intravenous infusion followed 2 weeks later by a second 300 mg intravenous infusion. Subsequent doses (starting 6 months from the first infusion): single 300 mg intravenous infusion every 6 months.

Side Effects: The most commonly reported uplizna side effects include:

  • Urinary tract infection
  • Arthralgia

Warnings and Precautions:

Monitor patients with lurbinectedin injection for infusion reactions during and for at least one hour after the completion of the infusion. Patients should be assessed for the tuberculosis risk factors and tested for latent infection prior to initiating inebilizumab-cdon. Monitor the levels of quantitative serum immunoglobulins while on therapy with lurbinectedin 100 mg, mainly in patients with opportunistic or recurrent infections, and until B-cell repletion after discontinuation of therapy. Patients are advised that the uplizna uses may cause reactivation of hepatitis B infection and that monitoring will be needed in case they are at risk. Administration of live-attenuated or live vaccines is not recommended while receiving uplizna dose until B-cell recovery. Patients who are pregnant or plan to become pregnant while taking uplizna injection should inform their health specialist.

More info

Storage: Store in a refrigerator at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light. Neither freeze nor shake it. Store vials upright. Availability in India: The Indian Pharma helps connect buyers with suppliers who can ship the UPLIZNA at the global level as per the needs of buyer’s. The Indian Pharma provides guarantee of quality as well as delivery for the UPLIZNA Injections. Buying Procedure: In order to buy UPLIZNA, you can contact us at our Toll-free number 1800 889 1064 or on WhatsApp number +919310090915 or an Email to us at: info@theindianpharma.com along with the legitimate ID Proof, standard Prescription and Medical Reports. Conclusions: Findings demonstrated that the treatment with inebilizumab provides a robust reduction in the risk of NMOSD attacks regardless of attack evaluation method, attack type, patient demographics, or previous therapy.

FAQ

What is Uplizna? Uplizna is a humanized anti-CD19 monoclonal antibody. It is introduced for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adults. What does Uplizna contain as an active substance? The medication Uplizna specifically contains the active substance Inebilizumab-cdon. How much does uplizna cost? The uplizna price in India usually can vary depending on the wholesaler/pharmacy you visit. Uplizna is available as a brand name drug only, a generic version is not yet available. What is the best price for Inebilizumab-cdon? Please contact Toll-free: +91 1800 889 1064|+919310090915 for inebilizumab-cdon 100 mg price in India. We take the guarantee of quality and delivery anywhere in the world as per the buyer’s requirements. Can I get Uplizna (Inebilizumab-cdon) even if I am not based in India? The Indian Pharma helps patients in accessing or importing Uplizna (Inebilizumab-cdon), not approved in their home country against the legitimate prescription and in conformity with the all local laws and regulations of their home country.

×